Topic Listing for NPS Pharmaceuticals

Access Data Accounting Impairment Long-lived Assets
Acknowledgment Acknowledgment Statement Decision Regarding Election
Action Without Meeting Actual Participation
Additional Data Being Presented Ddw Adjournment Notice Adjourned Meetings
Adjustment Awards Occurrence Certain Unusual Nonrecurring Events Adjustment Performance-based Compensation
Adjustments Authorized Shares Administration
Advertising Promotional Materials Affidavit Mailing
Affiliate Aga Clinical Science Plenary Session
Agents Service Process Aggregated Option Exercises 2004 Year-end Value Table
Aggregated Option Exercises 2005 Year-end Value Agreement
Agreement Amgen Promote Kineret Terminated Prior Initial Term Agreement Purchase Sale
Allocation Liability Alterations Additions
Amendment Amendment Agreement 2007 Between
Amendment Conform Law Amendment Indenture
Amendment Modification Suspension Termination Amendments
Amendments Articles Incorporation Bylaws Change Amendments Indenture
Amgen Inc Annual Award Limits
Annual Meeting Annual Meeting Stockholders 2008 Proxy Solicited Behalf Board
Annual Meetings Annual Nonretainer Equity Compensation
Annual Report Antitakeover Provisions Certificate Incorporation Bylaws Stockholder Rights Plan
Appendices Approval 2005 Omnibus Incentive Plan
Approved Products Product Candidates Undergoing Regulatory Review Articipation Ithdrawal Ermination
Assignment Subletting Astrazeneca
Attend Annual Meeting Attorneys Fees
Audit Committee Audit Committee Report
Audit Rights Adjustments Authority Board
Available Information Award
Award Agreement Awards Previously Granted
Base Case Amortization Schedule Base Salary
Base Salary Determinations Basis Presentation
Bear Cost Soliciting Votes Annual Meeting Because Never Marketed Sold Distributed Product Unable Successfully
Because Uncertainty Pharmaceutical Pricing Reimbursement Healthcare Reform Measures Bedminster New Jersey 2008
Beneficial Owner Beneficiary Designation
Benefit Sequential Therapy Osteoporosis Bill Sale
Bill Sale Assignment Ground Lease Bill Sale Assignment Ground Lease Contracts
Board Action Board Directors
Board Directors Recommends Vote Amendment 1998 Stock Option Board Directors Recommends Vote Amendments 2005 Omnibus Incentive
Board Discretion Board Recommend Vote
Board Update Breach Tenant
Brokers Business Highlights
Business Highlights Revised 2007 Financial Guidance Business Pipeline Update
Business Product Candidate Update Business Strategy
Business Update Calcilytics
Call Information Capital Stock Transactions
Cash Equivalents Cash Flow Not Sufficient Cover Interest Payments Convertible
Cash Flow Not Sufficient Cover Interest Payments Notes Cash Investments
Cash Sign-on Bonuses Cash-based Award
Cautionary Statement Purpose Safe Harbor Provisions Private Securities Cautionary Statement Regarding Forward-looking Statements
Central Nervous System Disorders Ceo Evaluation Compensation
Ceo Retention Bonus Certain Relationships Related Transactions
Certificate Legend Change Vote Revoke Proxy
Changes Disagreements Accountants Accounting Financial Disclosure Chief Medical Commercial Officer
Cinacalcet Cinacalcet Hcl
Cinacalcet Hcl Hyperparathyroidism Class Payoff Date
Classes Directors Clinical Program Advancements
Closing Closing Certificate
Code Code Ethics
Collaboration Astrazeneca Collaborative License Agreements
Collaborative Research Development License Agreements Collaborator Glaxosmithkline
Commercialization Territory Commitments Contingencies
Committee Committee Membership Organization Governance
Committees Committees Board
Common Areas Common Stock Purchase Agreement
Common Stock Purchase Agreement Compliance Certificate Common Stock Purchase Agreement Form Optional Amount Notice
Communication Stockholders Compensation Committee
Compensation Committee Interlocks Insider Participation Compensation Committee Report
Compensation Consultant Compensation Directors
Compensation Executive Officers Compensation Policy
Compensation Policy Objectives Competition
Compliance Changing Regulation Corporate Governance Public Disclosure Result Compliance Exchange Act
Compliance Laws Composite Copy
Compound Description Comprehensive Income Loss
Comprehensive Loss Concentration Suppliers
Condemnation Conditions Precedent
Conference Call Information Conference Call Scheduled Eastern Time Today
Conference Call Scheduled Est Today Conference Call Today
Conference Call Today 500 Conference Call Today 800
Conference Call Today 830 Conference Call Today 900
Conference Call Webcast Information Conference Call Webcast Scheduled Eastern Time Today
Confidentiality Publicity Consent Independent Registered Public Accounting Firm
Consolidated Balance Sheets Data Constraint Corporate Action
Consulting Agreement Plexus Contact Information
Contents Contractual Maturities Long-term Debt Obligations
Controls Procedures Conversion Notes Dilute Ownership Interest Existing Stockholders Including
Conversion Notice Convertible Notes
Convertible Notes Payable Convertible Notes Payment
Corporate Governance Committee Corporate Governance Guidelines Code Ethics
Corporate Pipeline Update Corporate Seal
Corporate Transactions Cost Reductions Capital Structure
Covenants Covered Employee
Creation Corporate Compliance Program Creation Disclosure Controls Committee
Critical Accounting Policies Critical Accounting Policies Estimates
Crohns Disease Current Nps Stockholders Objection Settlement Fee Award Not
Current Report Pursuant Securities Exchange Act 1934 Curtis Mallet-prevost Colt Mosle Llp
D-serine Analog Damage Destruction
Daniel Drucker Ddw
Declaration Dividends Default Remedies
Deferral Compensation Deferral Nonretainer Equity Compensation
Deferred Compensation Deferred Stock Units
Definitions Delegation
Delegation Authority Delivery Title
Departure Directors Certain Officers Election Appointment Compensatory Departure Directors Principal Officers Election Appointment
Departure Directors Principal Officers Election Appointment Compensatory Derivative Action
Derivative Actions Description Premises
Destruction Sellers Estate Development
Development Efforts Manner Performance Reports Development Responsibilities
Director Independence Directors
Directors Executive Officers Registrant Directors Officers
Discharge Indenture Disclosure Fair Value Financial Instruments
Discretionary Bonus Dispossession
Distribution License Agreement Distributions
Dividend Equivalents Dividend Reserve
Djustments Pon Changes Tock Dministration
Domestic Relations Orders Drug Royalty
Drug Royalty Corporation Inc Drc Duration
Duration Amendment Termination Duration Plan
Duties Chairman Board Directors Duties Chief Executive Officer
Duties Chief Financial Officer Duties President
Duties Secretary Duties Vice Presidents
Earnest Money Escrow Provisions Earning Performance Units Shares
Easements Ecurities Wned Orporation
Eferred Tock Nit Ward Greement Effect Certain Corporate Events
Effect Certain Corporate Transactions Election
Election Directors Electronic Delivery Future Stockholder Communications
Eli Lilly Canada Eligibility
Eligibility Participation Employee
Employee Benefit Plan Employee Organization Objectives
Employee Stock Purchase Plan Employees
Employees Based Outside United States Employees Other Agents
Employment Employment Agreements
Enforcement Entry Landlord
Entry Material Definitive Agreement Entry Material Definitive Agreements
Entry Material Definitive Contract Equity Compensation Plan Information
Equity Incentive Plan Ermination Uspension Lan
Esignation Eneficiary Establishment
Establishment Purpose Duration Estimates
Estoppel Certificate Estricted Tock Nit Greement
Evaluation Performance Exact Name Registrant Specified Charter
Exchange Act Exchange Act 1934
Executing Preclinical Clinical Studies Not Gaining Marketing Approvals Execution Corporate Instruments
Execution Other Securities Execution Version
Executive Committee Executive Compensation
Executive Officers Registrant Executive Vice President Coo
Exercise Freestanding Sars Exercise Options
Exercise Price Valuation Exercise Tandem Sars
Exhibits Existing Party Agreement Payments
Expenses Explanatory
Factual Background Actions Fail Attract Retain Key Employees Development Commercialization Products
Failure Receive Notice Fair Market Value
Federal Income Tax Consequences Fees
Fees Compensation Fees Expenses
Ffective Ate Lan Fficers
Ffices Final Decision-making Dispute Resolution
Final Judgment Approving Settlement Dismissal Actions Finance Objectives
Financial Guidance Financial Provisions
Financial Results Financial Statements Exhibits
Financial Statements Supplementary Data Find Voting Results Annual Meeting
Fixed Request Terms Optional Amount Fixing Record Dates
Following Shown Informational Purposes Only Tax Parcel 16-03-400-002-2007 Foreign Currency Translation
Forfeiture Bonuses Profits Restatements Forfeiture Events
Form 10-k Form 10-k Amendment
Form 10-q Form Certificate
Form Certificate Delivered Connection Transfers Pursuant Regulation Form Certificate Dtc Regarding Interest
Form Convertible Form Deed
Form Distribution Report Class Notes Form Dtc Certificate Regarding Interest
Form Execution Certificates Form Officers Certificate
Form Opinion Assistant General Counsel Form Opinion Foley Lardner Llp
Form Timing Payment Performance Units Shares Form Transfer Notice
Former Name Address Changed Since Last Report Forward-looking Statements
Fractional Shares Freestanding Sar
Full Value Award Fundamental Change
Further Assurances Gain Sale Asset
Gain Sale Fixed Assets Gastrointestinal Disorders
Gattex Gattex Teduglutide
Gattex8482 Teduglutide Gender Number
General General Administrative
General Indemnity General Information
Glaxosmithkline Goodwill
Goodwill Identifiable Intangible Assets Governing Law
Grant Cash-based Awards Grant Cash-based Awards Subject Terms Provisions Plan Board
Grant Options Grant Performance Units Shares
Grant Price Grant Restricted Stock Units
Grant Sars Ground Lease
Ground Lease Nps Operations Risk Loss Ground Lease Operations Risk Loss
Ground Lessor Estoppel Certificate Guarantee Vendors Obligations
Hares Tock Hares Ubject Lan
Hazardous Materials Help Answer Questions
Highlights Hills Drive Floor Bedminster 07921 Address Principal Executive
Historical Severance Arrangements History
History Operating Losses Expect Incur Net Never Achieve Holding Over
Householding Proxy Materials Ights Tockholder
Ights Urchase Rice Ignatures
Immediate Release 10-18 Immediate Release 10-3-07
Impairment Charges Important Trabecular Cortical Bone-building Effects
In-license Purchase Agreements Inability Obtain Authority
Incentive Stock Option Incentive Stock Options
Include Broader Territory Rights Preotact Inclusion Income
Income Tax Income Taxes
Indemnification Indemnification Agreements
Indemnification Directors Executive Officers Other Employees Agents Indemnity
Indemnity Agreement Independence Board
Index Individual Performance
Infringement Licensed Technology Insider
Insider Trading Controls Inspection
Inspectors Election Insurance
Interest Expense Interest Expense Net
Internal Discovery Research Internal Revenue Code 1986
Introduction Inventory
Investment Representations Involved Purported Securities Class Action Litigation Shareholder Derivative
Irectors Iscal Ear
Issuance Deferred Stock Units Istribution Greement
Ividends Janssen Pharmaceutica
Joint Development Committee Joint Owners Stock
Kineret Kirin Brewery Ltd
Landlord Entitled Rely Each Representations Warranties Certifications Capitalized Lands
Lease Agreement Lease Financing Obligation
Lease Financing Obligations Leases
Legal Description Land Legal Proceedings
Legend Leveraging Discovery Heritage
Liability Successors Licensed Technology
Licenses Existing Party Agreements Ligibility
List Chattels List Property Information
List Stockholders Long-term Debt Obligations
Long-term Incentive Compensation Loss Impairment Marketable Investment Securities
Loss Investment Loss Investments
Loss Marketable Investment Securities Loss Per Common Share
Lost Certificates Major Research Development Projects
Management Committee Manufacture Supply
Manufacturing Market Registrants Common Equity Related Stockholder Matters
Marketable Investment Securities Mars Discovery District
Maximizing Preos Value Meetings
Meetings Executive Session Mendment Lan
Mendments Metabotropic Glutamate Receptor Mglur Compounds
Methods Notice Mglurs
Milestone Payments Milestones
Miscellaneous Miscellaneous Provisions
Mnibus Ncentive Lan Modification
Modifications 2007 Sti Program Modifications Sti Program
Mortgagee Protection Mployee Tock Urchase Lan
Name Person Filing Proxy Statement Other Registrant Never Develop Commercial Drugs Other Products Generate Revenues
New Business Plan Expense Reductions New Drug Development Approval Process
New Path Study Analyses New Plan Benefits
New Sales Force Promoting Kineret Rheumatologists New Top Study Analyses
Nominating Committee Nominating Corporate Governance Committee
Nominees Board Amendment 1998 Stock Option Plan Ratification Nominees Election
Non-employee Directors Stock Bonus Program Non-employee Directors Stock Option Plan
Non-exclusivity Rights Non-reliance Previously Issued Financial Statements Related Audit
Nonemployee Director Award Nonemployee Director Stock Ownership Guidelines
Nonemployee Directors Nonemployee Directors Stock Bonus Program
Nonemployee Directors Stock Option Plan Nonexclusivity Plan
Nonqualified Stock Option Not Gaining Marketing Approvals Gattex Npsp558
Not Receive Regulatory Approval Market Gattex Timely Manner Not Successful Management Transition Attracting Retaining Team Members
Noteworthy Changes Over Notice Addresses
Notice Directors Notice Meetings
Notice Person Communication Unlawful Notice Person Undeliverable Address
Notice Proposed Settlement Derivative Actions Hearing Thereon Right Notice Stockholders
Notices Notification Disqualifying Disposition
Nps Nps Allelix Corp
Nps Announces Aggressive Plan Restructure Operations Cut Costs Nps Announces Legal Staff Changes
Nps Elects Anthony Coles Chief Executive Officer Nps Grants Assignments
Nps Pharmaceuticals Nps Pharmaceuticals Announces Approval Cinacalcet Hcl Japan
Nps Pharmaceuticals Announces Planned Sale Common Stock Nps Pharmaceuticals Announces Results Tender Offer
Nps Pharmaceuticals Announces Sale Facilities Nps Pharmaceuticals Announces Sale Preotact Royalty Drug Corporation
Nps Pharmaceuticals Announces Senior Management Appointments Nps Pharmaceuticals Announces Senior Management Changes
Nps Pharmaceuticals Appoints Colin Broom Board Directors Nps Pharmaceuticals Files Shelf Registration Statement
Nps Pharmaceuticals Inc Nps Pharmaceuticals Inc Announces Increase Tender Offer Price
Nps Pharmaceuticals Inc Safe Harbor Statement Nps Pharmaceuticals Names Brian Ocallaghan New Chief Commercial
Nps Pharmaceuticals Nycomed Announce Licensing Agreement Gattex Territories Nps Pharmaceuticals Provides Update Gattex Clinical Development Short
Nps Pharmaceuticals Reports 2008 Financial Results Business Update Nps Pharmaceuticals Reports Financial Results
Nps Provides Update Preos Nda Process Timing Nps Receives Approvable Letter Preos Nda
Nps Sells Assets Related Mglur Collaboration Astrazeneca Support Nps Updates Status Preos Nda
Nps-controlled Patent Rights Npsp558
Npsp558 Parathyroid Hormone 1-84 Npsp558 Parathyroid Hormone 1-84 Rdna Origin Injection
Number 0-23272 Number Shares Available Awards
Number Term Office Nycomed
Nycomed Danmark Aps Nycomed Grants
Oans Fficers Obtain Copy Npss 2008 Annual Report Stockholders Form
Obtain Separate Set Proxy Materials Request Single Household Officers
Officers Designated Omnibus Incentive Plan
Omnibus Plan Ontario Inc
Operating Principles Operating Results
Operating Segments Operations Involve Hazardous Materials Comply Environmental Laws Regulations
Option Option Exercise
Option Exercises Stock Vested 2006 Option Extend
Option Grants 2004 Option Price
Organization Organization Summary Significant Accounting Policies
Orporate Eal Ortho-mcneil Pharmaceuticals Inc
Osteoporosis Other
Other Agreements Financings Other Committees
Other Events Other Expense Net
Other Information Other Matters
Other Offices Other Ongoing Rights Responsibilities
Other Research Development Programs Other Restrictions
Other Stock-based Award Other Stock-based Awards
Ovenants Ompany Overview
Overview Sti Program Target Awards Ownership Inventions
Ownership Regulatory Submissions Parsippany
Parsippany New Jersey 07054 Part
Part Defined Terms Part Table Concordance
Participant Participation
Partnered Programs Partnership 2007
Party Infringement Party Patent Infringement
Party Service Provider Party Trademark Infringement
Patents Other Proprietary Technology Path Study Design One-year Results
Patients Short Bowel Syndrome Payment
Payment Award Dates Payment Cash-based Awards Other Stock-based
Payment Royalties Net Sales Payments Amgen Kirin Cinacalcet Hc1
Peer Group 2008 Decisions Peer Group 2009 Decisions
Performance Goals Performance Measurement Comparison
Performance Measures Performance Period
Performance Share Performance Unit
Performance Units Shares Performance-based Compensation
Period Restriction Permitted Encumbrances
Perquisites Person
Phase Proof-of-concept Study Results Phase Results
Pipeline Objectives Pipeline Update
Place Meetings Plaintiffs Counsels Fees Reimbursement Expenses
Plan Distribution Plant Equipment
Plus Royalties Policy Regarding Deductibility
Possession Post Termination Compensation
Postmenopausal Women Osteoporosis Potential Payments Termination Change Control
Powers Preos
Preos Calcilytic Compounds Osteoporosis Preos Hypoparathyroidism
Preos Nda Preos Nda Filed Fda
Preos New Drug Application Accepted Review Fda Preos Parathyroid Hormone Rdna Origin Injection
Preotact Full-length Parathyroid Hormone Pth 1-84 Principal Accountant Fees Services
Principles Consolidation Private Securities Litigation Reform Act 1995
Procedure Indemnification Proceeds Used Retire Convertible Debt Notes Due 2008
Proceeds Used Retire Notes Due 2008 Process
Product Product Development Programs
Product Liability Claims Brought Against Unable Obtain Maintain Product Pipeline
Product Pipeline Update Products Product Candidates Infringe Intellectual Property Rights Others
Progress Executing New Business Plan Reiterates Guidance Prohibition Repricing Awards
Properties Property Purchase Price
Prorations Adjustments Prosecution Maintenance Patent Rights
Prosecution Maintenance Product Trademarks Provisions Private Securities Litigation Reform Act 1995
Proxy Properly Executed Voted Directed Above Direction Election Proxy Solicited Behalf Board Directors
Ptionee Purchase Price
Purchase Sale Agreement Purchase Sale Sellers Estate
Purpose Purpose Committee
Purpose Plan Pursuant Usc 1350 Adopted 906 Sarbanes-oxley Act 2002
Quantitative Qualitative Disclosures Market Risk Quarterly Financial Data
Quarterly Period 2006 Quarterly Period 2007
Quiet Enjoyment Quitclaim Deed
Quorum Quorum Voting
Rant Ights Ffering Ratification Selection Independent Registered Public Accountants
Reasons Settlement Recalls Market Withdrawals Corrective Actions
Receiving Materials Recent Accounting Pronouncements
Recent Corporate Developments Recitals
Reclassifications Reform Act 1995
Registered Office Registered Stockholders
Registrants Telephone Number Including Area Code Registration Rights Agreement
Registration Statement Regular Meetings
Regulatory Correspondence Regulatory Review Europe
Releases Relocation Assistance
Remedies Breach Removal
Rent Report Independent Registered Public Accounting Firm
Representations Warranties Representations Warranties Investor
Representations Warranties Parent Representations Warranties Purchaser
Repricing Reprioritizing Development Portfolio
Require Additional Funds Requirements Law
Research Development Research Development Expenses
Resignation Resignations
Resources Additional Authority Committee Responsibilities Authority
Responsibilities Board Restatement 2007 Financial Results
Restricted Stock Unit Restricted Stock Unit Agreement
Restricted Stock Units Restrictions Share Transferability
Restrictions Transfer Restructuring Charges
Restructuring Decrease Cash Burn Result 2006 Restructuring Initiative Related Reductions Workforce Reallocated
Result 2007 2006 Restructuring Initiatives Related Reductions Workforce Result Intense Competition Technological Change Pharmaceutical Industry Marketplace
Results Operations Results Operations Financial Condition
Retirement Participant Retirement Welfare Plans
Return Receipt Requested Revenue Recognition
Revenues Review Approval Transactions Related Persons
Revises Financial Guidance Revocability Proxies
Right Appear Object Right Purchase
Rights Participants Rights Stockholder
Risk Factors Roceeds Rom Tock
Role Board Directors Compensation Committee Role Executives Compensation Decisions
Rule 10b5-1 Plans Rule 13a-14 15d-14 Certification
Rules Construction Defined Terms Safe Harbor Statement
Sale Assignment Sale Premises Landlord
San Diego California 2008 Sar Agreement
Sarbanes-oxley 302 Certification Sarbanes-oxley Act 2002
Saving Clause Sbs
Schedule Schedule 14a
Schedule 14a Rule 14a-101 Schedule Buyers
Schedules Science Business Review
Secured Class Notes Secured Notes Payable
Securities Class Action Securities Exchange Act 1934
Securities Registered Pursuant Act Securities Registered Pursuant Act Common Stock 001 Par
Security Ownership Certain Beneficial Owners Management Selected Quarterly Financial Data
Seller Estoppel Certificate Sellers After Closing
Selling General Administrative Expenses Selling Restrictions
Selling Stockholders Setting Executive Compensation
Settlement Sar Amount Severability
Severance Period Each Job Classification Share Usage
Shared Development Costs Shareholder Nominated Proposals
Shares Available Awards Shares Present Represented Conduct Business Annual Meeting
Shares Registered Name Shares Registered Name Broker Bank
Short Bowel Syndrome Sbs Short Term Incentive Award
Short-term Incentive Compensation Signature Page Follows
Signatures Signatures Following Page
Signs Advertising Solicitation
Source Shares Common Stock Issuable Program Special Meetings
Special Regarding Forward-looking Statements Special Warranty Deed
Sponsored Government Funded Research Programs State Other Jurisdiction Incorporation
Statements Press Release Not Historical Nature Constitute Forward-looking Statistical Analysis
Status Regulatory Approvals Stock Appreciation Right
Stock Appreciation Rights Stock Option Plan
Stock Options Stock Price Been Continue Volatile Investment Common Suffer
Stock Subject Plan Stock Withholding
Stock-based Compensation Stockholder Proposals
Stockholder Rights Plan Strategy
Study Design Top-line Results Subject Extensive Government Regulations Cause Cancel Delay Introduction
Sublease Submission Matters Vote Security Holders
Subordination Subordination Attornment
Subsequent Events Subsidiary
Substantial Future Sales Common Stock Existing Stockholders Cause Substantially Dependent Ability Successfully Timely Complete Clinical Trials
Successor Ceo Hunter Jackson Phd Successor Trustees
Successors Summary
Summary 2006 Achievements Supply After Assigning Marketing Authorizations Approvals Nycomed Request
Surrender Lease Surrender Premises
Survey Certification Survival Rights
Table Contents Tandem Sar
Tax Withholding Taxes
Teduglutide Telephone Meetings
Tenure Duties Officers Term
Term Options Term Sar
Term Termination Termination
Termination Amendment Termination Employment
Termination Employment Change-in-control Arrangements Termination Lease Agreement
Termination Participants Employment Services Termination Survival
Terms Options Terms Settlement
Ther Ecurities Orporation Time Notices Deemed Given
Title Title Survey Review
Tockholders Eetings Trade Accounts Receivable
Trademark Infringement Trademarks
Transferability Transferability Awards
Transfers Transfers Non-qib Accredited Investors
Trustee Types Awards
Ulsba Board Directors Guidelines Unable Obtain Patents Protect Technologies Other Companies Competitive
Uncertificated Shares Undersigned Understands Foregoing Election Not Revoked Except Consent
Unfunded Plan Upcoming Milestones
Update 2007 Milestones Urpose
Utilities Services Vacancies
Value Cash-based Other Stock-based Awards Value Performance Units Shares
Ventiv Health Ventiv Health Inc Safe Harbor Statement
Vote Confidential Vote Directors
Vote Internet Wwwproxyvotecom Vote Mail
Vote Phone 1-800-690-6903 Vote Proposal
Vote Shares Person Annual Meeting Vote Shares Without Attending Annual Meeting
Votes Counted Voting Rights
Voting Rights Outstanding Shares Voting Securities Owned Corporation
Voting Via Internet Telephone Waiver Notice
Waiver Release Agreement What Business Voted Annual Meeting
What Deadline Propose Actions Consideration Next Annual Meeting What Deadline Voting Shares
What Difference Between Holding Shares Stockholder Record Beneficial What Happens Additional Matters Presented Annual Meeting
What Information Contained Proxy Statement What Questions Npss Transfer Agent
What Receive Set Voting Materials What Shares Vote
What Voting Requirement Approve Each Proposals Whereas
Whippany New Jersey 07981 Withholding
Withholding Generally Witness Whereof
Witness Whereof Parties Hereto Executed Amendment Agreement Date Xercise
Year-end Operating Results 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki